Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, SIMARD JOHN, holds the title of Director at XBiotech Inc..
On 2026-11-03, the insider transacted 70,000 shares.The shares were transacted at a weighted average price of $2.05 per share, resulting in a total market-relevant value of $143K.
SIMARD JOHN (Director) bought $143K of $XBIT
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.